Designing a Clinical Trial for Severe AI in Moderate and Low Risk Patients: Is it Feasible?

Monday, February 27, 2023

3:23 PM – 3:31 PM ET

Speaker(s)

Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

Disclosure(s): Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

Disclosure(s):

Michael J. Reardon, MD: Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)